002198 嘉应制药
已收盘 07-15 15:00:00
资讯
新帖
简况
嘉应制药获得外观设计专利授权：“包装盒（双料喉风散）”
证券之星 · 07-11
嘉应制药获得外观设计专利授权：“包装盒（双料喉风散）”
嘉应制药新提交4件商标注册申请
证券之星 · 07-04
嘉应制药新提交4件商标注册申请
【嘉应制药：聘任曾勇为公司财务负责人】金融界6月27日消息，嘉应制药公告称，2025年6月27日公司召开第七届董事会第八次临时会议，经公司总经理游永平提名，董事会提名委员会审查、董事会审计委员会审议，同意聘任曾勇担任公司财务负责人，任职期限自本次董事会审议通过之日起至第七届董事会届满之日止 。
金融界 · 06-27
【嘉应制药：聘任曾勇为公司财务负责人】金融界6月27日消息，嘉应制药公告称，2025年6月27日公司召开第七届董事会第八次临时会议，经公司总经理游永平提名，董事会提名委员会审查、董事会审计委员会审议，同意聘任曾勇担任公司财务负责人，任职期限自本次董事会审议通过之日起至第七届董事会届满之日止 。
嘉应制药：公司现有产品中暂无中药创新药
互动易 · 06-26
嘉应制药：公司现有产品中暂无中药创新药
老牌药企被立案调查 董事长涉嫌挪用2.35亿资金
深蓝财经 · 05-29
老牌药企被立案调查 董事长涉嫌挪用2.35亿资金
ST联合拟购买润田实业100%股权；嘉应制药因涉嫌信披违法违规被中国证监会立案｜公告精选
每日经济新闻 · 05-28
ST联合拟购买润田实业100%股权；嘉应制药因涉嫌信披违法违规被中国证监会立案｜公告精选
嘉应制药(002198)5月20日股东户数2.4万户，较上期增加0.63%
证券之星 · 05-27
嘉应制药(002198)5月20日股东户数2.4万户，较上期增加0.63%
每周股票复盘：嘉应制药（002198）子公司签署中药创新药开发合同
证券之星 · 05-24
每周股票复盘：嘉应制药（002198）子公司签署中药创新药开发合同
嘉应制药(002198.SZ)与湖南中医药大学签署技术开发合同
智通财经 · 05-23
嘉应制药(002198.SZ)与湖南中医药大学签署技术开发合同
嘉应制药：子公司与湖南中医药大学签署技术开发合同
格隆汇 · 05-23
嘉应制药：子公司与湖南中医药大学签署技术开发合同
嘉应制药：关于公司财务总监辞职的公告
新浪财经-鹰眼工作室 · 05-19
嘉应制药：关于公司财务总监辞职的公告
嘉应制药(002198.SZ)财务总监史俊平辞职
智通财经 · 05-19
嘉应制药(002198.SZ)财务总监史俊平辞职
嘉应制药(002198)4月10日股东户数2.38万户，较上期增加1.74%
证券之星 · 04-21
嘉应制药(002198)4月10日股东户数2.38万户，较上期增加1.74%
【嘉应制药：2025年第一季度报告披露时间提前至4月25日】嘉应制药公告，公司原定于2025年4月30日披露2025年第一季度报告。现经向深圳证券交易所申请并获同意，披露时间变更为2025年4月25日。
金融界 · 04-14
【嘉应制药：2025年第一季度报告披露时间提前至4月25日】嘉应制药公告，公司原定于2025年4月30日披露2025年第一季度报告。现经向深圳证券交易所申请并获同意，披露时间变更为2025年4月25日。
2月17日嘉应制药涨停分析：养老产业，医药，中药概念热股
证券之星 · 02-17
2月17日嘉应制药涨停分析：养老产业，医药，中药概念热股
异动快报：嘉应制药（002198）2月17日10点19分触及涨停板
证券之星 · 02-17
异动快报：嘉应制药（002198）2月17日10点19分触及涨停板
嘉应制药(002198)1月27日股东户数2.21万户，较上期减少2.73%
证券之星 · 02-10
嘉应制药(002198)1月27日股东户数2.21万户，较上期减少2.73%
嘉应制药：截至2025年1月27日股东人数为22,149
金融界 · 02-10
嘉应制药：截至2025年1月27日股东人数为22,149
加载更多
公司概况
公司名称：
广东嘉应制药股份有限公司
所属行业：
医药制造业
上市日期：
2007-12-18
主营业务：
广东嘉应制药股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是双料喉风散、双料喉风含片、重感灵片、银翘解毒颗粒、橘红痰咳颗粒、接骨七厘片、接骨七厘胶囊、消炎利胆片、金菊五花茶颗粒、壮腰健肾丸、固精参茸丸、桂附理中丸、胃痛片、吐泻肚痛胶囊。2024年公司“嘉应牌”荣登首批广东老字号名单。
发行价格：
5.99
{"stockData":{"symbol":"002198","market":"SZ","secType":"STK","nameCN":"嘉应制药","latestPrice":6.43,"timestamp":1752562986000,"preClose":6.56,"halted":0,"volume":8254315,"delay":0,"changeRate":-0.0198,"floatShares":508000000,"shares":508000000,"eps":0.0608,"marketStatus":"已收盘","change":-0.13,"latestTime":"07-15 15:00:00","open":6.54,"high":6.57,"low":6.4,"amount":53325600,"amplitude":0.0259,"askPrice":6.43,"askSize":91,"bidPrice":6.42,"bidSize":282,"shortable":0,"etf":0,"ttmEps":0.0608,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1752629400000},"marketStatusCode":5,"adr":0,"adjPreClose":6.56,"symbolType":"stock","openAndCloseTimeList":[[1752543000000,1752550200000],[1752555600000,1752562800000]],"highLimit":7.22,"lowLimit":5.9,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":507509848,"isCdr":false,"pbRate":4.6,"roa":"--","peRate":105.756579,"roe":"2.08%","epsLYR":0.0406,"committee":0.05194,"marketValue":3263000000,"turnoverRate":0.0163,"status":1,"floatMarketCap":3263000000},"requestUrl":"/m/hq/s/002198","defaultTab":"news","newsList":[{"id":"2550387966","title":"嘉应制药获得外观设计专利授权：“包装盒（双料喉风散）”","url":"https://stock-news.laohu8.com/highlight/detail?id=2550387966","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550387966?lang=zh_cn&edition=full","pubTime":"2025-07-12 02:46","pubTimestamp":1752259581,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示嘉应制药新获得一项外观设计专利授权，专利名为“包装盒”，专利申请号为CN202430704173.6，授权日为2025年7月11日。今年以来嘉应制药新获得专利授权1个。通过天眼查大数据分析，广东嘉应制药股份有限公司共对外投资了4家企业，参与招投标项目152次；财产线索方面有商标信息82条，专利信息12条；此外企业还拥有行政许可268个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071200003072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198","BK0077","BK0239"],"gpt_icon":0},{"id":"2549831548","title":"嘉应制药新提交4件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2549831548","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549831548?lang=zh_cn&edition=full","pubTime":"2025-07-05 05:58","pubTimestamp":1751666333,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示，近日广东嘉应制药股份有限公司新提交4件商标注册申请。商标申请详情如下：今年以来广东嘉应制药股份有限公司新申请注册商标4件，截止目前公司共持有注册商标96件，另有23件商标尚在注册申请中。通过天眼查大数据分析，广东嘉应制药股份有限公司共对外投资了4家企业，参与招投标项目151次；财产线索方面有商标信息72条，专利信息11条；此外企业还拥有行政许可210个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070500005281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198","BK0077","BK0239"],"gpt_icon":0},{"id":"2546103667","title":"【嘉应制药：聘任曾勇为公司财务负责人】金融界6月27日消息，嘉应制药公告称，2025年6月27日公司召开第七届董事会第八次临时会议，经公司总经理游永平提名，董事会提名委员会审查、董事会审计委员会审议，同意聘任曾勇担任公司财务负责人，任职期限自本次董事会审议通过之日起至第七届董事会届满之日止 。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546103667","media":"金融界","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546103667?lang=zh_cn&edition=full","pubTime":"2025-06-27 18:51","pubTimestamp":1751021494,"startTime":"0","endTime":"0","summary":"金融界6月27日消息，嘉应制药公告称，2025年6月27日公司召开第七届董事会第八次临时会议，经公司总经理游永平提名，董事会提名委员会审查、董事会审计委员会审议，同意聘任曾勇担任公司财务负责人，任职期限自本次董事会审议通过之日起至第七届董事会届满之日止 。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/27185151356615.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0077","002198"],"gpt_icon":0},{"id":"2546227268","title":"嘉应制药：公司现有产品中暂无中药创新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2546227268","media":"互动易","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546227268?lang=zh_cn&edition=full","pubTime":"2025-06-26 11:51","pubTimestamp":1750909860,"startTime":"0","endTime":"0","summary":"有投资者向嘉应制药提问， 请问公司的产品中有创新药吗？公司回答表示，尊敬的投资者，您好！公司现有产品中暂无中药创新药。公司将持续关注中药创新药的行业发展趋势及市场需求变化，谢谢！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626115500a71e23b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626115500a71e23b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0077","159992","BK0239","002198","561510","562390"],"gpt_icon":0},{"id":"2539268848","title":"老牌药企被立案调查 董事长涉嫌挪用2.35亿资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2539268848","media":"深蓝财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539268848?lang=zh_cn&edition=full","pubTime":"2025-05-29 18:00","pubTimestamp":1748512800,"startTime":"0","endTime":"0","summary":"查阅嘉应制药过往公告，可以发现其此次被立案调查并非毫无预兆。1内部控制重大缺陷嘉应制药此次被立案调查与其内部控制存在的重大缺陷密切相关。根据公告，自2024年9月至2025年1月期间，嘉应制药全资子公司嘉应湖南累计向四家公司转出资金约2.35亿元。除资金占用，嘉应制药还存在关联交易未及时披露的情况。另外，嘉应制药的独立董事李善伟也出现违规行为。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU1Njc1NjA2NA==&mid=2247589672&idx=4&sn=b80564dabc453bb33754fc3b7f21e613&chksm=fab094060b37cc8060e2cce2d3d212e9eee5e03ff6b973326f309b59a4e3795871d0bdef1e63&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["BK0239","002198","BK0077"],"gpt_icon":0},{"id":"2538303474","title":"ST联合拟购买润田实业100%股权；嘉应制药因涉嫌信披违法违规被中国证监会立案｜公告精选","url":"https://stock-news.laohu8.com/highlight/detail?id=2538303474","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538303474?lang=zh_cn&edition=full","pubTime":"2025-05-28 21:53","pubTimestamp":1748440436,"startTime":"0","endTime":"0","summary":"ST联合股票将于5月29日复牌。该公司股票因触及交易类强制退市情形被作出终止上市决定，不进入退市整理期。嘉应制药：因涉嫌信息披露违法违规被中国证监会立案嘉应制药于5月28日收到中国证监会的《立案告知书》，因公司涉嫌信息披露违法违规，中国证监会决定对公司立案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505282157159505bbaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505282157159505bbaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600358","BK0239","BK0102","BK0077","BK0217","BK0116","002198"],"gpt_icon":0},{"id":"2538345951","title":"嘉应制药(002198)5月20日股东户数2.4万户，较上期增加0.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538345951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538345951?lang=zh_cn&edition=full","pubTime":"2025-05-27 17:12","pubTimestamp":1748337145,"startTime":"0","endTime":"0","summary":"证券之星消息，近日嘉应制药披露，截至2025年5月20日公司股东户数为2.4万户，较4月18日增加151.0户，增幅为0.63%。在中药行业个股中，嘉应制药股东户数低于行业平均水平，截至5月20日，中药行业平均股东户数为5.26万户。从股价来看，2025年4月18日至2025年5月20日，嘉应制药区间涨幅为7.11%，在此期间股东户数增加151.0户，增幅为0.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052700026141.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","002198"],"gpt_icon":0},{"id":"2537195335","title":"每周股票复盘：嘉应制药（002198）子公司签署中药创新药开发合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2537195335","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537195335?lang=zh_cn&edition=full","pubTime":"2025-05-24 19:01","pubTimestamp":1748084482,"startTime":"0","endTime":"0","summary":"截至2025年5月23日收盘，嘉应制药报收于6.69元，较上周的6.96元下跌3.88%。本周，嘉应制药5月19日盘中最高价报7.1元。嘉应制药当前最新总市值33.95亿元，在中药板块市值排名49/69，在两市A股市值排名3849/5148。本周关注点公司公告汇总：嘉应制药全资子公司与湖南中医药大学签署《技术开发合同》，共同开发中药创新药1.1类“蠲痹历节清颗粒”。合同期限为5年。广东嘉应制药股份有限公司董事会于2025年5月24日发布此公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052400013425.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002198","159992","BK1161","BK0077","BK1574","BK0239","06978"],"gpt_icon":0},{"id":"2537293185","title":"嘉应制药(002198.SZ)与湖南中医药大学签署技术开发合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2537293185","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537293185?lang=zh_cn&edition=full","pubTime":"2025-05-23 16:48","pubTimestamp":1747990108,"startTime":"0","endTime":"0","summary":"智通财经APP讯，嘉应制药 发布公告，近日，公司全资子公司嘉应制药(湖南)有限公司与湖南中医药大学签署《技术开发合同》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1296894.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"嘉应制药(002198.SZ)与湖南中医药大学签署技术开发合同","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0239","002198"],"gpt_icon":0},{"id":"2537183777","title":"嘉应制药：子公司与湖南中医药大学签署技术开发合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2537183777","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537183777?lang=zh_cn&edition=full","pubTime":"2025-05-23 16:31","pubTimestamp":1747989117,"startTime":"0","endTime":"0","summary":"格隆汇5月23日丨嘉应制药(002198.SZ)公布，近日，广东嘉应制药股份有限公司全资子公司嘉应制药(湖南)有限公司(简称“子公司”或“乙方”)与湖南中医药大学(简称“甲方”)签署《技术开发合同》。双方共同参与研究开发中药创新药1.1类-蠲痹历节清颗粒联合开发项目，“蠲痹历节清”处方是甲方临床使用多年的有效经验方。为满足临床需求，甲乙双方通过临床前研究及评估，注册申报，共同完成中药创新药1.1类“蠲痹历节清颗粒”的临床批件申请申报涉及的相关技术研究工作，并获得药物临床试验批准通知书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523163158a4896044&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523163158a4896044&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002198","BK0239","561510","BK0077","562390"],"gpt_icon":0},{"id":"2536935503","title":"嘉应制药：关于公司财务总监辞职的公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2536935503","media":"新浪财经-鹰眼工作室","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536935503?lang=zh_cn&edition=full","pubTime":"2025-05-19 16:20","pubTimestamp":1747642800,"startTime":"0","endTime":"0","summary":"广东嘉应制药股份有限公司关于公司财务总监辞职的公告本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。广东嘉应制药股份有限公司董事会于近日收到公司财务总监史俊平先生提交的书面辞职报告。公司将按照相关规定尽快完成财务总监的选聘工作，并及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-05-19/doc-inexavfy2847184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002198","BK0077","BK0239"],"gpt_icon":0},{"id":"2536570654","title":"嘉应制药(002198.SZ)财务总监史俊平辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2536570654","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536570654?lang=zh_cn&edition=full","pubTime":"2025-05-19 15:45","pubTimestamp":1747640750,"startTime":"0","endTime":"0","summary":"智通财经APP讯，嘉应制药(002198.SZ)发布公告，公司董事会于近日收到公司财务总监史俊平先生提交的书面辞职报告。史俊平先生因个人原因辞去公司财务总监职务，根据相关规定，其辞职报告自送达董事会之日起生效，辞任后不再担任公司任何职务，也不会影响公司的正常运行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1294748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0077","BK0239","002198"],"gpt_icon":0},{"id":"2529827379","title":"嘉应制药(002198)4月10日股东户数2.38万户，较上期增加1.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529827379","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529827379?lang=zh_cn&edition=full","pubTime":"2025-04-21 17:18","pubTimestamp":1745227102,"startTime":"0","endTime":"0","summary":"证券之星消息，近日嘉应制药披露，截至2025年4月10日公司股东户数为2.38万户，较3月31日增加406.0户，增幅为1.74%。在中药行业个股中，嘉应制药股东户数低于行业平均水平，截至4月10日，中药行业平均股东户数为5.23万户。从股价来看，2025年3月31日至2025年4月10日，嘉应制药区间跌幅为10.55%，在此期间股东户数增加406.0户，增幅为1.74%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042100022633.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002198","BK0239"],"gpt_icon":0},{"id":"2527137523","title":"【嘉应制药：2025年第一季度报告披露时间提前至4月25日】嘉应制药公告，公司原定于2025年4月30日披露2025年第一季度报告。现经向深圳证券交易所申请并获同意，披露时间变更为2025年4月25日。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527137523","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527137523?lang=zh_cn&edition=full","pubTime":"2025-04-14 18:42","pubTimestamp":1744627325,"startTime":"0","endTime":"0","summary":"嘉应制药公告，公司原定于2025年4月30日披露2025年第一季度报告。现经向深圳证券交易所申请并获同意，披露时间变更为2025年4月25日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/04/14184249527241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0077","BK0239","002198"],"gpt_icon":0},{"id":"2512915983","title":"2月17日嘉应制药涨停分析：养老产业，医药，中药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2512915983","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512915983?lang=zh_cn&edition=full","pubTime":"2025-02-17 15:29","pubTimestamp":1739777351,"startTime":"0","endTime":"0","summary":"证券之星消息，嘉应制药2月17日涨停收盘，收盘价7.71元。该股于10点19分涨停，7次打开涨停，截止收盘封单资金为94.14万元，占其流通市值0.02%。近5日资金流向一览见下表：该股为养老产业，医药，中药概念热股，当日养老产业概念上涨1.6%，医药概念上涨0.57%，中药概念上涨0.34%。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021700013970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK1574","09939","BK1515","399812","002198","BK0077","BK0239","BK1161"],"gpt_icon":0},{"id":"2512967796","title":"异动快报：嘉应制药（002198）2月17日10点19分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2512967796","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512967796?lang=zh_cn&edition=full","pubTime":"2025-02-17 10:20","pubTimestamp":1739758838,"startTime":"0","endTime":"0","summary":"证券之星2月17日盘中消息，10点19分嘉应制药触及涨停板。目前价格7.71，上涨9.99%。其所属行业中药目前下跌。该股为养老产业，医药，中药概念热股，当日养老产业概念上涨1.67%，医药概念上涨0.69%，中药概念上涨0.41%。2月14日的资金流向数据方面，主力资金净流出1696.69万元，占总成交额35.79%，游资资金净流入1144.67万元，占总成交额24.14%，散户资金净流入552.02万元，占总成交额11.64%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021700005369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002198","BK0239"],"gpt_icon":0},{"id":"2510836197","title":"嘉应制药(002198)1月27日股东户数2.21万户，较上期减少2.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510836197","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510836197?lang=zh_cn&edition=full","pubTime":"2025-02-10 17:09","pubTimestamp":1739178569,"startTime":"0","endTime":"0","summary":"证券之星消息，近日嘉应制药披露，截至2025年1月27日公司股东户数为2.21万户，较1月10日减少621.0户，减幅为2.73%。在中药行业个股中，嘉应制药股东户数低于行业平均水平，截至1月27日，中药行业平均股东户数为5.03万户。从股价来看，2025年1月10日至2025年1月27日，嘉应制药区间跌幅为2.41%，在此期间股东户数减少621.0户，减幅为2.73%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021000021792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","002198"],"gpt_icon":0},{"id":"2510000148","title":"嘉应制药：截至2025年1月27日股东人数为22,149","url":"https://stock-news.laohu8.com/highlight/detail?id=2510000148","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510000148?lang=zh_cn&edition=full","pubTime":"2025-02-10 12:09","pubTimestamp":1739160559,"startTime":"0","endTime":"0","summary":"金融界2月10日消息，有投资者在互动平台向嘉应制药提问：请问截止1月27日收盘公司股东数是多少？谢谢。公司回答表示：截止2025年1月27日，根据中登下发的股东名册，公司股东人数为22,149。\n\n\r\n 责任编辑：磐石","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/10120948042427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0077","002198","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752587993038,"stockEarnings":[{"period":"1week","weight":0.0314},{"period":"1month","weight":0.0564},{"period":"3month","weight":-0.0253},{"period":"6month","weight":-0.0602},{"period":"1year","weight":-0.0106},{"period":"ytd","weight":-0.1038}],"compareEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":0.0422},{"period":"3month","weight":0.0771},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1846},{"period":"ytd","weight":0.0501}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东嘉应制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"25570人(较上一季度减少4.46%)","perCapita":"19847股","listingDate":"2007-12-18","address":"广东省梅州市梅江区东升工业园B区","registeredCapital":"50750万元","survey":" 广东嘉应制药股份有限公司的主营业务是中成药的研发、生产和销售。公司的主要产品是双料喉风散、双料喉风含片、重感灵片、银翘解毒颗粒、橘红痰咳颗粒、接骨七厘片、接骨七厘胶囊、消炎利胆片、金菊五花茶颗粒、壮腰健肾丸、固精参茸丸、桂附理中丸、胃痛片、吐泻肚痛胶囊。2024年公司“嘉应牌”荣登首批广东老字号名单。","listedPrice":5.99},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"嘉应制药(002198)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供嘉应制药(002198)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"嘉应制药,002198,嘉应制药股票,嘉应制药股票老虎,嘉应制药股票老虎国际,嘉应制药行情,嘉应制药股票行情,嘉应制药股价,嘉应制药股市,嘉应制药股票价格,嘉应制药股票交易,嘉应制药股票购买,嘉应制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"嘉应制药(002198)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供嘉应制药(002198)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}